| Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (NCT04064346) | Palladio Biosciences | 2021-10-28 |
| Kidney Sodium Functional Imaging (NCT05014178) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-09-16 |
| Analysis of Patients With Autosomal Dominant Polycystic Kidney (NCT06759142) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-02-20 |
| Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT04680780) | University of Cologne | 2021-01-10 |
| Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and Salt (NCT04310319) | Esther Meijer | 2020-09-07 |
| Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (NCT04152837) | Palladio Biosciences | 2020-09-02 |
| Short Term Induction of Ketosis in PKD (NCT04472624) | University of Cologne | 2020-07-01 |
| Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study (NCT04338048) | Children's Hospital of Philadelphia | 2019-10-10 |
| A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (NCT03918447) | Biogen | 2019-05-29 |
| Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease (NCT03764605) | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 2019-01-30 |
| ADPKD Alterations in Hepatic Transporter Function (NCT03717883) | University of North Carolina, Chapel Hill | 2018-09-17 |
| Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD (NCT03203642) | Kadmon, a Sanofi Company | 2017-10-12 |
| Statin Therapy in Patients With Early Stage ADPKD (NCT03273413) | University of Colorado, Denver | 2017-08-31 |
| Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (NCT02776241) | Rigshospitalet, Denmark | 2015-09-01 |
| Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping (NCT02161068) | The Rogosin Institute | 2013-12-01 |
| Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT01853553) | University of Colorado, Denver | 2013-07-01 |
| The Vienna RAP Pilot Study (NCT01632605) | Medical University of Vienna | 2009-11-01 |
| Genetics in the Progression of Nephropathies (NCT06416761) | Ospedale San Raffaele | 2006-05-19 |
| Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis (NCT00345137) | Regional Hospital Holstebro | |